These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The hemagglutination-inhibition assay for thrombopoietin. McDonald TP Blood; 1973 Feb; 41(2):219-33. PubMed ID: 4707614 [No Abstract] [Full Text] [Related]
5. Partial purification of a thrombocytopoiesis stimulating factor present in the serum of thrombocytopenic rats. Dassin E; Bourebia J; Najean Y; Rosset AM Acta Haematol; 1983; 69(4):249-53. PubMed ID: 6402880 [TBL] [Abstract][Full Text] [Related]
6. A comparison of platelet size, latelet count, and platelet 35S incorporation as assays for thrombopoietin. McDonald TP Br J Haematol; 1976 Oct; 34(2):257-67. PubMed ID: 974039 [TBL] [Abstract][Full Text] [Related]
7. Studies on the purification of thrombopoietin from kidney cell culture medium. McDonald TP; Cottrell M; Clift R; Khouri JA; Long MD J Lab Clin Med; 1985 Aug; 106(2):162-74. PubMed ID: 4020244 [TBL] [Abstract][Full Text] [Related]
8. A comparison of mice in rebound-thrombocytosis with platelet-hypertransfused mice for the assay of thrombopoietin. McDonald TP; Clift R; Nolan C; Tribby II Scand J Haematol; 1976 May; 16(5):326-34. PubMed ID: 951576 [TBL] [Abstract][Full Text] [Related]
9. Current status of thrombopoietin. McDonald TP Adv Exp Med Biol; 1988; 241():243-53. PubMed ID: 3066161 [No Abstract] [Full Text] [Related]
10. Lysis of rabbit platelets by F(ab') 2 antibody fragments. Siraganian RP; Sandberg AL; Osler AG J Immunol; 1972 Oct; 109(4):907-9. PubMed ID: 4116363 [No Abstract] [Full Text] [Related]
11. Effects of hypoxia on thrombocytopoiesis and thrombopoietin production of mice. McDonald TP; Cottrell M; Clift R Proc Soc Exp Biol Med; 1979 Mar; 160(3):335-9. PubMed ID: 432242 [No Abstract] [Full Text] [Related]
12. The production of a highly specific antibody to human platelets. Dzoga K; Stoltzner G; Wissler RW Lab Invest; 1972 Oct; 27(4):351-6. PubMed ID: 4627561 [No Abstract] [Full Text] [Related]
13. Characterization of contrasensitizing antibodies. Crowle AJ; Yonemasu K; Hu CC; Fujita Y Cell Immunol; 1974 Mar; 11(1-3):272-85. PubMed ID: 4218132 [No Abstract] [Full Text] [Related]
14. [Thrombocytopoietic effect induced by repeated administration of antithrombocyte serum]. Cserháti I Orv Hetil; 1976 Aug; 117(35):2103-5. PubMed ID: 967417 [No Abstract] [Full Text] [Related]
15. Platelet aggregation and release triggered by antibody to platelet factor 4 (PF4). Niewiarowski S; Lukasiewicz H; Nath N Proc Soc Exp Biol Med; 1974 Oct; 147(1):188-94. PubMed ID: 4140521 [No Abstract] [Full Text] [Related]
16. Platelet injury due to activation of the alternate complement pathway. Siraganian RP; Sandberg AL; Alexander A; Osler AG J Immunol; 1973 Feb; 110(2):490-7. PubMed ID: 4119252 [No Abstract] [Full Text] [Related]
18. Requirements for antibody in the immune complex-induced platelet aggregation reaction. Palosuo T; Hurme M Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Feb; 81(1):143-9. PubMed ID: 4125693 [No Abstract] [Full Text] [Related]
19. Studies of platelet production and sequestration in the experimental animal. Penington DG Proc R Soc Med; 1968 Jun; 61(6):601-3. PubMed ID: 5688679 [No Abstract] [Full Text] [Related]
20. DFP labeling of platelets during recovery from thrombocytopenia. Ebbe S; Sapienza P; Duffy P; Stohlman F Blood; 1970 May; 35(5):613-23. PubMed ID: 4910962 [No Abstract] [Full Text] [Related] [Next] [New Search]